NewCo News: Fast and 'Furiex' Route in Drug Development for PPD Spinout
By Jennifer Boggs
Thursday, July 28, 2011
Contract research organizations (CRO) have been ramping up their roles in drug development, usually by partnering with or taking equity stakes in biotech firms. But PPD Inc. took the trend a step further last year when it spun out drug development company Furiex Pharmaceuticals Inc.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.